Clinical Research Directory
Browse clinical research sites, groups, and studies.
Sphenopalatine Block vs Dexmedetomidine Infusion in Trans Nasal Endoscopic Pituitary Surgery
Sponsor: Zagazig University
Summary
Improving pain and surgical field by using sphenopalatine ganglion block and dexmedetomidine in trans-nasal endoscopic pituitary surgery.
Official title: Bilateral Supra-Zygomatic Sphenopalatine Ganglion Block Versus Dexmedetomidine for Relief of Postoperative Pain and Surgical Field Improvement in Trans-nasal Endoscopic Pituitary Surgery
Key Details
Gender
All
Age Range
21 Years - 64 Years
Study Type
INTERVENTIONAL
Enrollment
69
Start Date
2024-10-01
Completion Date
2026-10
Last Updated
2026-01-02
Healthy Volunteers
No
Interventions
Sphenopalatine Ganglion Block
patients will receive ultrasound guided bilateral supra-zygomatic sphenopalatine ganglion block.
Dexmedetomidine
patients will receive 1 µg/kg dexmedetomidine within 10 minutes, followed by maintenance dose throughout the surgery.
General Anesthesia (control group)
patients will be operated under general anesthesia including routine protocol for these cases
Locations (1)
Zagazig Univesity Hospital
Zagazig, Egypt